Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2026
Translating Innovation Into Practice: Dissemination of Immune Checkpoint Inhibitors and Their Toxicity Management Across the GlobeMehak Trikha, Susan Dent, Kaysia Ludford, et al.Journal of the National Cancer Institute|April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal CancerKaysia Ludford, Romain Cohen, Magali Svrcek, et al.Nature Communications|May 15, 2025
Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid TumorsMichael LaPelusa, Wei Qiao, Bryan Iorgulescu, et al.The Oncologist|July 20, 2026
Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapyMichael LaPelusa, Preksha Shah, Deepak Bhamidipati, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancerDaniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2025
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal CancerVan K Morris, Weihong Xiao, Kangyu Lin, et al.Cancer Research Communications|December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment TerminationKristen Simmons, Jane V Thomas, Kaysia Ludford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid TumorsKaysia Ludford, Won Jin Ho, Jane V Thomas, et al.Journal for Immunotherapy of Cancer|February 27, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantationChantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, et al.Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.Pageof 1